Curcumin-cyclodextrin complexes potentiate gemcitabine effects in an orthotopic mouse model of lung cancer

British Journal of Cancer

Volumn 107, Issue 7, 2012, Pages 1083-1092

  Rocks, N ^a   Bekaert, S ^a   Coia, I ^a   Paulissen, G ^a   Gueders, M ^a   Evrard, B ^a   Van Heugen, J C ^a   Chiap, P ^a   Foidart, J M ^a   Noel, A ^a   Cataldo, D ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

cell cycle; curcumin; cyclodextrin; gemcitabine; lung cancer

Indexed keywords

CURCUMIN; GAMMA CYCLODEXTRIN DERIVATIVE; GEMCITABINE; HYDROXYPROPYL GAMMA CYCLODEXTRIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PLACEBO; TETRAHYDROXYCURCUMIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER MODEL; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG FORMULATION; DRUG POTENTIATION; DRUG SOLUBILITY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIQUID CHROMATOGRAPHY; LUNG CANCER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; TUMOR CELL; TUMOR VOLUME; TUMOR XENOGRAFT; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CELL PROLIFERATION; CURCUMIN; CYCLODEXTRINS; DEOXYCYTIDINE; DRUG SYNERGISM; G2 PHASE; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; TUMOR CELLS, CULTURED;

EID: 84866897574     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.379     Document Type: Article

References (28)

1. Aggarwal BB, Banerjee S, Bharadwaj U, Sung B, Shishodia S, Sethi G (2007) Curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell lines. Biochem Pharmacol 73: 1024-1032
2. Aggarwal BB, Shishodia S, Takada Y, Banerjee S, Newman RA, Bueso-Ramos CE, Price JE (2005) Curcumin suppresses the paclitaxelinduced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res 11: 7490-7498
3. American Cancer Society. Cancer Facts & Figures 2010. American Cancer Society: Atlanta, 2010 Binder D, Hubner RH, Temmesfeld-Wollbruck B, Schlattmann P (2011) Pulmonary toxicity among cancer patients treated with a combination of docetaxel and gemcitabine: a meta-analysis of clinical trials. Cancer Chemother Pharmacol 68: 1575-1583
4. Chen HW, Lee JY, Huang JY, Wang CC, Chen WJ, Su SF, Huang CW, Ho CC, Chen JJ, Tsai MF, Yu SL, Yang PC (2008) Curcumin inhibits lung cancer cell invasion and metastasis through the tumor suppressor HLJ1. Cancer Res 68: 7428-7438
5. Duarte VM, Han E, Veena MS, Salvado A, Suh JD, Liang LJ, Faull KF, Srivatsan ES, Wang MB (2010) Curcumin enhances the effect of cisplatin in suppression of head and neck squamous cell carcinoma via inhibition of IKKbeta protein of the NFkappaB pathway. Mol Cancer Ther 9: 2665-2675
6. Evrard B, Bertholet P, Gueders M, Flament MP, Piel G, Delattre L, Gayot A, Leterme P, Foidart JM, Cataldo D (2004) Cyclodextrins as a potential carrier in drug nebulization. J Control Release 96: 403-410
7. Kanai M, Yoshimura K, Asada M, Imaizumi A, Suzuki C, Matsumoto S, Nishimura T, Mori Y, Masui T, Kawaguchi Y, Yanagihara K, Yazumi S, Chiba T, Guha S, Aggarwal BB (2011) A phase I/II study of gemcitabinebased chemotherapy plus curcumin for patients with gemcitabineresistant pancreatic cancer. Cancer Chemother Pharmacol 68: 157-164
8. Kunnumakkara AB, Anand P, Aggarwal BB (2008) Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 269: 199-225
9. Kunnumakkara AB, Guha S, Krishnan S, Diagaradjane P, Gelovani J, Aggarwal BB (2007) Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products. Cancer Res 67: 3853-3861
10. Lin YG, Kunnumakkara AB, Nair A, Merritt WM, Han LY, Armaiz-Pena GN, Kamat AA, Spannuth WA, Gershenson DM, Lutgendorf SK, Aggarwal BB, Sood AK (2007) Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factorkappaB pathway. Clin Cancer Res 13: 3423-3430
11. Nasrallah H, Bar-Sela G, Haim N (2012) Fatal interstitial lung disease associated with gemcitabine and erlotinib therapy for lung cancer. Med Oncol 29: 212-214
12. Noel A, Jost M, Maquoi E (2008) Matrix metalloproteinases at cancer tumor-host interface. Semin Cell Dev Biol 19: 52-60
13. Patel BB, Majumdar AP (2009) Synergistic role of curcumin with current therapeutics in colorectal cancer: minireview. Nutr Cancer 61: 842-846
14. Paulovich AG, Toczyski DP, Hartwell LH (1997) When checkpoints fail. Cell 88: 315-321
15. Pawlik TM, Keyomarsi K (2004) Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys 59: 928-942
16. Ravindran J, Prasad S, Aggarwal BB (2009) Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? AAPS J 11: 495-510
17. Rocks N, Estrella C, Paulissen G, Quesada Calvo F, Gilles C, Gueders M, Crahay C, Foidart JM, Gosset P, Noel A, Cataldo D (2008a) The metalloproteinase ADAM-12 regulates bronchial epithelial cell proliferation and apoptosis. Cell Prolif 41: 988-1001
18. Rocks N, Paulissen G, Quesada-Calvo F, Munaut C, Gonzalez ML, Gueders M, Hacha J, Gilles C, Foidart JM, Noel A, Cataldo DD (2008b) ADAMTS-1 metalloproteinase promotes tumor development through the induction of a stromal reaction in vivo. Cancer Res 68: 9541-9550
19. Saha A, Kuzuhara T, Echigo N, Fujii A, Suganuma M, Fujiki H (2010) Apoptosis of human lung cancer cells by curcumin mediated through up-regulation of 'growth arrest and DNA damage inducible genes 45 and 153'. Biol Pharm Bull 33: 1291-1299
20. Shankar S, Ganapathy S, Chen Q, Srivastava RK (2008) Curcumin sensitizes TRAIL-resistant xenografts: molecular mechanisms of apoptosis, metastasis and angiogenesis. Mol Cancer 7: 16
21. Sreekanth CN, Bava SV, Sreekumar E, Anto RJ (2011) Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer. Oncogene 30: 3139-3152
22. Srivastava RK, Chen Q, Siddiqui I, Sarva K, Shankar S (2007) Linkage of curcumin-induced cell cycle arrest and apoptosis by cyclin-dependent kinase inhibitor p21(/WAF1/CIP1). Cell Cycle 6: 2953-2961
23. Tharakan ST, Inamoto T, Sung B, Aggarwal BB, Kamat AM (2010) Curcumin potentiates the antitumor effects of gemcitabine in an orthotopic model of human bladder cancer through suppression of proliferative and angiogenic biomarkers. Biochem Pharmacol 79: 218-228
24. Vermeulen K, Van Bockstaele DR, Berneman ZN (2003) The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif 36: 131-149
25. Wang D, Veena MS, Stevenson K, Tang C, Ho B, Suh JD, Duarte VM, Faull KF, Mehta K, Srivatsan ES, Wang MB (2008) Liposomeencapsulated curcumin suppresses growth of head and neck squamous cell carcinoma in vitro and in xenografts through the inhibition of nuclear factor kappaB by an AKT-independent pathway. Clin Cancer Res 14: 6228-6236
26. Yadav VR, Prasad S, Kannappan R, Ravindran J, Chaturvedi MM, Vaahtera L, Parkkinen J, Aggarwal BB (2010) Cyclodextrin-complexed curcumin exhibits anti-inflammatory and antiproliferative activities superior to those of curcumin through higher cellular uptake. Biochem Pharmacol 80: 1021-1032
27. Yodkeeree S, Chaiwangyen W, Garbisa S, Limtrakul P (2009) Curcumin, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and uPA. J Nutr Biochem 20: 87-95
28. Zhongfa L, Chiu M, Wang J, Chen W, Yen W, Fan-Havard P, Yee LD, Chan KK (2012) Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice. Cancer Chemother Pharmacol 69: 679-689